Clinical Trials Directory

Trials / Completed

CompletedNCT00390702

Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System

International Multicentre Clinical Device Investigation on Safety and Effectiveness of the Nit-Occlud® Lê VSD Spiral Coil System for VSD Occlusion Developed by Pfm AG, Cologne

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
pfm medical gmbh · Industry
Sex
All
Age
2 Years
Healthy volunteers
Not accepted

Summary

The Ventricular septal defect (VSD) is the most common of all congenital cardiac malformations. By modifying the Nit-Occlud® PDA Device the Nit-Occlud® Lê VSD Spiral System was designed. as a percutaneous, transcatheter device for occlusion of (peri)membranous and muscular ventricular septum defects (VSD) with a spiral coil. In this clinical investigation feasibility, safety and performance of the new cardiac occluder will be evaluated in accordance with European and US regulations. The study data will be compared to performance criteria for VSD, which are deduced analogue to the published specific Objective Performance Criteria (OPCs) for PDAs. The first part of the study has been performed in three clinical centres in Germany. For the second part in April 2009 four additional clinical centres in Germany, Israel, Italy and Spain were included.

Conditions

Interventions

TypeNameDescription
DEVICEtranscatheter implantation of a VSD occluder (Nitinol coil)transcatheter implantation, by first performing a arterial-venous loop through the defect

Timeline

Start date
2006-10-01
Primary completion
2012-08-01
Completion
2017-05-01
First posted
2006-10-20
Last updated
2018-11-07

Locations

6 sites across 2 countries: Germany, Israel

Source: ClinicalTrials.gov record NCT00390702. Inclusion in this directory is not an endorsement.